EconPapers    
Economics at your fingertips  
 

Exploring the Impacts of Green Supply Chain Integration and Ambidextrous Green Innovation on the Financial Performance of China’s Pharmaceutical Manufacturing Enterprises

Guimei Yang, Feng Liu and Putthiwat Singhdong ()
Additional contact information
Guimei Yang: Faculty of Business Administration, Rajamangala University of Technology Thanyaburi, Pathum Thani 12110, Thailand
Feng Liu: Faculty of Business Administration, Rajamangala University of Technology Thanyaburi, Pathum Thani 12110, Thailand
Putthiwat Singhdong: Faculty of Business Administration, Rajamangala University of Technology Thanyaburi, Pathum Thani 12110, Thailand

Sustainability, 2024, vol. 16, issue 15, 1-23

Abstract: This study focuses on the factors affecting the financial performance of pharmaceutical manufacturing enterprises. Based on dynamic capability theory and ambidextrous innovation theory, this study adopts the Resource–Behavior–Performance framework to investigate how green supply chain integration (GSCI) and ambidextrous green innovation affect financial performance. The proposed hypotheses were tested through structural equation modeling using data from 400 China’s pharmaceutical manufacturing enterprises. The results indicate that the various dimensions of GSCI and ambidextrous green innovation yield distinct outcomes. Among the three dimensions of GSCI, only green supplier integration and green customer integration significantly impact financial performance directly, unlike green internal integration. Among the two dimensions of ambidextrous green innovation, only exploitative green innovation significantly influences financial performance, acting as a mediator between the GSCI dimensions and financial performance, while exploratory green innovation does not. The main advantages of this study include considering the connotation and value of GSCI from a green dynamic capability perspective, as well as the effects of exploratory and exploitative green innovation as intermediary behaviors while simultaneously considering the performance effects of GSCI and ambidextrous green innovation. This study offers novel academic insights and practical guidelines for pharmaceutical manufacturing enterprises to integrate GSCI and ambidextrous green innovation, with the aim of achieving better financial performance in their sustainable development efforts.

Keywords: green supply chain integration; exploratory green innovation; exploitative green innovation; financial performance; pharmaceutical manufacturing enterprises (search for similar items in EconPapers)
JEL-codes: O13 Q Q0 Q2 Q3 Q5 Q56 (search for similar items in EconPapers)
Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/2071-1050/16/15/6501/pdf (application/pdf)
https://www.mdpi.com/2071-1050/16/15/6501/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jsusta:v:16:y:2024:i:15:p:6501-:d:1445958

Access Statistics for this article

Sustainability is currently edited by Ms. Alexandra Wu

More articles in Sustainability from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().

 
Page updated 2025-03-19
Handle: RePEc:gam:jsusta:v:16:y:2024:i:15:p:6501-:d:1445958